|Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration|
JM Wardlaw, EE Smith, GJ Biessels, C Cordonnier, F Fazekas, R Frayne, ...
The Lancet Neurology 12 (8), 822-838, 2013
|Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient …|
J Emberson, KR Lees, P Lyden, L Blackwell, G Albers, E Bluhmki, T Brott, ...
The Lancet 384 (9958), 1929-1935, 2014
|The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke|
P Sandercock, R Collins, C Counsell, B Farrell, R Peto, J Slattery, ...
The Lancet 349 (9065), 1569, 1997
|Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage|
CS Anderson, E Heeley, Y Huang, J Wang, C Stapf, C Delcourt, R Lindley, ...
New England Journal of Medicine 368 (25), 2355-2365, 2013
|The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST …|
IST-3 Collaborative Group
The Lancet 379 (9834), 2352-2363, 2012
|Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis|
JM Wardlaw, V Murray, E Berge, G Del Zoppo, P Sandercock, RL Lindley, ...
The Lancet 379 (9834), 2364-2372, 2012
|Distinguishing between stroke and mimic at the bedside: the brain attack study|
PJ Hand, J Kwan, RI Lindley, MS Dennis, JM Wardlaw
Stroke 37 (3), 769-775, 2006
|Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke|
CS Anderson, T Robinson, RI Lindley, H Arima, PM Lavados, TH Lee, ...
New England Journal of Medicine 374 (24), 2313-2323, 2016
|Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial|
J Bernhardt, P Langhorne, RI Lindley, AG Thrift, F Ellery, J Collier, ...
Lancet 386 (9988), 46-55, 2015
|Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis|
P Masson, AC Webster, M Hong, R Turner, RI Lindley, JC Craig
Nephrology Dialysis Transplantation 30 (7), 1162-1169, 2015
|Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study|
C Delcourt, Y Huang, H Arima, J Chalmers, SM Davis, EL Heeley, J Wang, ...
Neurology 79 (4), 314-319, 2012
|Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.|
PA Sandercock, AG Van den Belt, RI Lindley, J Slattery
Journal of Neurology, Neurosurgery & Psychiatry 56 (1), 17-25, 1993
|Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial|
L Manning, Y Hirakawa, H Arima, X Wang, J Chalmers, J Wang, R Lindley, ...
The Lancet Neurology 13 (4), 364-373, 2014
|Sensory and cognitive association in older persons: findings from an older Australian population|
T Tay, JJ Wang, A Kifley, R Lindley, P Newall, P Mitchell
Gerontology 52 (6), 386-394, 2006
|Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis|
WN Whiteley, J Emberson, KR Lees, L Blackwell, G Albers, E Bluhmki, ...
The Lancet Neurology 15 (9), 925-933, 2016
|Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials|
KR Lees, J Emberson, L Blackwell, E Bluhmki, SM Davis, GA Donnan, ...
Stroke 47 (9), 2373-2379, 2016
|Thigh-length versus below-knee stockings for deep venous thrombosis prophylaxis after stroke: a randomized trial|
CLOTS (Clots in Legs Or sTockings after Stroke) Trial Collaboration*
Annals of internal medicine 153 (9), 553-562, 2010
|Prespecified dose-response analysis for a very early rehabilitation trial (AVERT)|
J Bernhardt, L Churilov, F Ellery, J Collier, J Chamberlain, P Langhorne, ...
Neurology 86 (23), 2138-2145, 2016
|MRC BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart …|
T Meade, P Sleight, R Collins, J Armitage, S Parish, R Peto, L Youngman, ...
European Heart Journal, 1999
|Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint …|
CS Anderson, Y Huang, RI Lindley, X Chen, H Arima, G Chen, Q Li, ...
The Lancet 393 (10174), 877-888, 2019